Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Journal of Hepatology|April 16, 2013
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Jürgen K Rockstroh, Lars Peters, Daniel Grint, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
Antiviral Therapy|January 30, 2016
Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all?Leah Shepherd, Álvaro H Borges, Lene Ravn, et al.
Journal of the International AIDS Society|November 14, 2014
Regional differences in self-reported HIV care and management in the EuroSIDA studyKamilla Grønborg Laut, Amanda Mocroft, Jeffrey Lazarus, et al.
Cancer|July 28, 2010
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignanciesJoanne Reekie, Csaba Kosa, Frederik Engsig, et al.
Tuberculosis Research and Treatment|April 19, 2021
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International LaboratoryDaria N Podlekareva, Dorte Bek Folkvardsen, Alena Skrahina, et al.
AIDS (London, England)|July 24, 2025
Elevated high-sensitivity C-reactive protein and triglycerides in people with HIV treated with lipid-lowering therapyAnna Katrine Haslund Roed, Anne Marie Reimer Jensen, Andreas Dehlbæk Knudsen, et al.
Antiviral Therapy|May 14, 2003
Changes in viral load in people with virological failure who remain on the same HAART regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Veronica Miller, et al.
AIDS (London, England)|April 15, 2015
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antiviralsDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Journal of Hepatology|April 16, 2013
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Jürgen K Rockstroh, Lars Peters, Daniel Grint, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
Antiviral Therapy|January 30, 2016
Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all?Leah Shepherd, Álvaro H Borges, Lene Ravn, et al.
Journal of the International AIDS Society|November 14, 2014
Regional differences in self-reported HIV care and management in the EuroSIDA studyKamilla Grønborg Laut, Amanda Mocroft, Jeffrey Lazarus, et al.
Cancer|July 28, 2010
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignanciesJoanne Reekie, Csaba Kosa, Frederik Engsig, et al.
Tuberculosis Research and Treatment|April 19, 2021
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International LaboratoryDaria N Podlekareva, Dorte Bek Folkvardsen, Alena Skrahina, et al.
AIDS (London, England)|July 24, 2025
Elevated high-sensitivity C-reactive protein and triglycerides in people with HIV treated with lipid-lowering therapyAnna Katrine Haslund Roed, Anne Marie Reimer Jensen, Andreas Dehlbæk Knudsen, et al.
Antiviral Therapy|May 14, 2003
Changes in viral load in people with virological failure who remain on the same HAART regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Veronica Miller, et al.
AIDS (London, England)|April 15, 2015
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antiviralsDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.
Pageof 18